Replies to post #283740 on Anavex Life Sciences Corp (AVXL)

[Bourbon_on_my_cornflakes]

Good thing superior Anavex management got Rett done!

Unfortunate news for the Rett community, as GW Pharmaceuticals has terminated their Rett study, citing global pandemic complications:

Dr. Missling got it done where GW failed. Objectively superior mgt at Anavex.

Rett girls wont need GW garbage when 273 becomes the standard of care.

[XenaLives]

LOL!!! It appears GW Pharma got the memo about blarcamesine!

[vg_future]

Thanks TTTav66. Here is the strange thing...GWPH went up by $2 today in spite of discontinuing the study (of course genuine reasons) whereas our stock stock continues to be beaten up everytime it releases good/great NEWS. Hope this treatment (of the stock I meant) changes soon.

Wishing the best to the RETT community which is badly in need of cure/solution.

-vg_future

To be clear. GWPH makes money on other products that got approved. So, RETT is just one of the many indications that they are pursuing.

[nidan7500]

This may also be a convenient time for others to back away. This could be a type of message. This may be one way potential AVXL competitors can drop out. For example if they have information that unbeatable progress is being made elsewhere...take a knee.

The RSD community is very tight, hard to keep a secret.

TTT

Unfortunate news for the Rett community, as GW Pharmaceuticals has discontinued their late stage, pediatric Rett study, citing global pandemic complications: https://www.rettsyndrome.org/wp-content/uploads/RSO-ARCH-update-Nov-12_2020.pdf?fbclid=IwAR1zT764utDULgfcWhwGFMGd2aFj2ECJl8nCLIaPZkkHWLotS7Xsu7fZESE

https://clinicaltrials.gov/ct2/show/NCT03848832

[McMagyar]

Well that sucks